Cargando…
P003 Synthetic antifungal peptide mimic kills Candida albicans by targeting protein glycosylation and synergistically prevents infection
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: Fungal infections represent a serious burden on human health. Increasing numbers of susceptible hosts, a limited set of approved antifungal drugs which frequently trigger undesired side effects, and the emergence of resistant strains highligh...
Autores principales: | Schaefer, Sebastian, Vij, Raghav, Sprague, Jakob, Seemann, Eric, Hube, Bernhard, Lenardon, Megan, Boyer, Cyrille, Brunke, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509771/ http://dx.doi.org/10.1093/mmy/myac072.P003 |
Ejemplares similares
-
Uncharted territories in the discovery of antifungal and antivirulence natural products from bacteria
por: Vij, Raghav, et al.
Publicado: (2021) -
Two unlike cousins: Candida albicans and C. glabrata infection strategies
por: Brunke, Sascha, et al.
Publicado: (2013) -
S9.3d Antivirulence drug discovery to disarm Candida albicans with metabolites from myxobacteria.
por: Vij, Raghav, et al.
Publicado: (2022) -
Encapsulation of Antifungals in Micelles Protects Candida albicans during Gall-Bladder Infection
por: Hsieh, Shih-Hung, et al.
Publicado: (2017) -
Candida albicans Hap43 Domains Are Required under Iron Starvation but Not Excess
por: Skrahina, Volha, et al.
Publicado: (2017)